参考文献/References:
[1] KALIA L V, LANG A E. Parkinson’s disease[J]. Lancet, 2015, 386(9996): 896-912.
[2] OERTEL F C, ZIMMERMANN H G, BRANDT A U, et al. Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis[J]. Expert Review of Neurotherapeutics, 2018, 27:1-13.
[3] CRISCUOLO C, CERRI E, FABIANI C, et al. The retina as a window to early dysfunctions of Alzheimer’s disease following studies with a 5xFAD mouse model[J]. Neurobiology of Aging, 2018, 67: 181-188.
[4] PAIVA F T M, SILVERSTEIN S M, BUTLER P D, et al. Color vision impairments in schizophrenia and the role of antipsychotic medication type[J]. Schizophr Research, 2018, S0920-9964(18): 30551-30556.
[5] LEE J Y, AHN J, KIM T W, et al. Optical coherence tomography in Parkinson’s disease: is the retina a biomarker?[J]. Journal of Parkinsons Disease, 2014, 4(2): 197-204.
[6] RAMIREZ A I, De HOZ R, SALOBRAR-GARCIA E, et al. The role of microglia in retinal neurodegeneration: Alzheimer’s disease, Parkinson, and glaucoma[J]. Frontiers in Aging Neuroscience, 2017, 9: 214-234.
[7] de MAINDREVILLE A D, FNELON G, MAHIEUX F. Hallucinations in Parkinson’s disease: a follow-up study[J]. Movement Disorders, 2005, 20(2): 212-217.
[8] ONOFRJ M, BONANNI L, ALBANI G, et al. Visual hallucinations in Parkinson’s disease: clues to separate origins[J]. Journal of the Neurological Sciences, 2006, 248(1/2): 143-150.
[9] SONG Fuhai, QIAN Ying, PENG Xing, et al. Perturbation of the transcriptome: implications of the innate immune system in Alzheimer’s disease[J]. Current Opinion in Pharmacology, 2016, 26: 47-53.
[10] ANNIBALI V, UMETON R, PALERMO A, et al. Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor(IRF)-1 pathway in multiple sclerosis patients[J]. Journal of Neuroimmunology, 2018, 324: 165-171.
[11] ENWRIGHT III J F, HUO Zhiguang, ARION D, et al. Transcriptome alterations of prefrontal cortical parvalbumin neurons in Schizophrenia[J]. Molecular psychiatry, 2018, 23(7): 1606-1613.
[12] SANDOR C, ROBERTSON P, LANG C, et al. Trans-criptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson’s disease[J]. Human Molecular Genetics, 2017, 26(3): 552-566.
[13] GANESHAN V, SKLADNEV N V, KIM J Y, et al. Preconditioning with remote photobiomodulation modulates the brain transcriptome and protects against MPTP insult in mice[J]. Neuroscience, 2019, 400: 85-97.
[14] HUANG Dawei, SHERMAN B T, LEMPICKI R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nature Protocols, 2009: 4(1): 44-57.
[15] HUANG Dawei, SHERMAN B T, LEMPICKI R A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists[J]. Nucleic Acids Research, 2009: 37(1): 1-13.
[16] SHARIFLOU S, GEORGEVSKY D, MANSOUR H, et al. Diagnostic and prognostic potential of retinal biomarkers in early on-set Alzheimer’s disease[J]. Current Alzheimer Research, 2017, 14(9): 1000-1007.
[17] KHOO T K, YARNALL A J, DUNCAN G W, et al. The spectrum of nonmotor symptoms in early Parkinson disease[J]. Neurology, 2013, 80(3): 276-281.
[18] ATHANASIOU D, AGUIL M, BELLINGHAM J, et al. The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy[J]. Progress in Retin Eye Reserach, 2017, 62:1-23.
[19] JACOBSON S G, CIDECIYAN A V, IANNACCONE A, et al. Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa[J]. Investigative Ophthalmology and Visual Science, 2000, 41(7): 1898-1908.
[20] BERGER A, LORAIN S, JOSEPhine C, et al. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa[J]. Molecular Therapy, 2015, 23(5): 918-930.
[21] XU Mingchu, XIE Yajing, ABOUZEID H, et al. Mutations in the spliceosome component, CWC27, cause retinal degeneration with or without additional developmental anomalies[J]. American Journal of Human Genetics, 2017, 100(4): 592-604.
[22] TANACKOVIC G, RANSIJN A, THIBAULT P, et al. PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa[J]. Human Molecular Genetics, 2011, 20(11): 2116-2130.
[23] SIDDIQUI I J, PERVAIZ N, ABBASI A A. The Parkinson disease gene SNCA: evolutionary and structural insights with pathological implication[J]. Scientific Reports, 2016, 6(1): 24475-24485.